Here Group is reaffirmed as a 'Buy' with a price target of $6.20, supported by the upcoming launch of new intellectual property (IP) Xiao Ao, which leverages celebrity Wang Yibo's popularity. This new IP is expected to outperform previous launches like SIINONO and significantly boost revenue through fiscal year 2027. While Wall Street targets a higher price of $7.80 per share, the analyst remains cautious due to risks related to concentration in Wakuku and execution uncertainties. The company maintains a strong balance sheet and ample cash reserves, supporting its asset-light, IP-driven growth strategy despite inherent market volatility.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
